13F-HR filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-13, with 43 holding rows worth $340,279,233.
- Accession
- 0001420506-24-001376
- Filer
- CIK 1952142
- Filed
- 2024-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 44 entries on the cover page, a total value of $340,279,233 stated on the cover page (in dollars after the unit check, H1), rows summing to $340,279,233 with VALUE read as dollars as filed, 13F file number 028-23724. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,412,176 | $28,991,973 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 2,712,741 | $28,673,672 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,011,879 | $26,713,606 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 551,095 | $24,683,545 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 288,668 | $17,080,486 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 280,709 | $15,492,330 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,495,047 | $14,830,866 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 339,351 | $11,500,605 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 2,211,320 | $10,326,864 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 81,508 | $10,153,452 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 245,933 | $9,468,421 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 2,662,732 | $9,266,307 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 965,392 | $8,978,146 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,178,105 | $8,812,225 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 736,765 | $8,679,092 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 233,255 | $8,096,281 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 1,848,582 | $5,848,164 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 502,207 | $5,835,645 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 251,010 | $5,828,452 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 86,980 | $5,827,660 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 144,467 | $5,346,724 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 704,349 | $5,106,530 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 845,069 | $4,943,654 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 271,057 | $4,881,737 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 101,479 | $4,591,925 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 696,464 | $4,318,077 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 203,273 | $4,242,308 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 1,202,675 | $3,980,854 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 92,949 | $3,893,634 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 101,787 | $3,573,742 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 150,450 | $3,537,080 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 343,810 | $3,427,786 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 143,775 | $3,263,693 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 674,198 | $3,141,763 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 744,412 | $2,977,648 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 78,601 | $2,860,290 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 124,866 | $2,372,454 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 984,113 | $2,046,955 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 200,000 | $2,044,000 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 143,510 | $1,571,435 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 150,000 | $1,509,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 29,259 | $1,210,152 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 5,000,000 | $350,000 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-001376 | this filing | 2024-08-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001420506-24-001418 | base | 2024-08-13 | acceptance time not in the bulk data set |